Citius Pharmaceuticals Inc (CTXR)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Citius Pharmaceuticals Inc (CTXR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014161
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc, is a specialty pharmaceutical company that focused on the development and commercialization of adjunctive cancer care and critical care drug products. The company‘s proprietary product candidates include mino-lok, an antibiotic lock solution used for the treatment of patients with catheter-related bloodstream infections; and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine intended for the treatment of persons suffering from mild to moderate hemorrhoids. Citius is headquartered in Cranford, New Jersey, the US.

Citius Pharmaceuticals Inc (CTXR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Leonard-Meron Biosciences Raises USD0.6 Million in Venture Financing 10
Licensing Agreements 11
Leonard Meron Biosciences Expands Licensing Agreement with Novel Anti-Infective Therapeutics 11
Equity Offering 12
Citius Pharma Plans to Raise up to USD50 Million in Public Offering of Shares and Warrants 12
Citius Pharma Raises USD6.8 Million in Public Offering of Shares and Warrants 13
Citius Pharma Raises USD0.8 Million in Third Tranche of Private Placement of Units 15
Citius Pharma Raises USD0.2 Million in Seconds Tranche of Private Placement of Units 16
Citius Pharma Plans to Raise Funds in Public Offering of Shares 17
Citius Pharma Raises USD0.4 Million in Private Placement of Units 18
Citius Pharma Raises USD4.6 Million in Private Placement of Units 19
Citius Pharma Raises USD3 Million in Private Placement of Shares 20
Citius Pharma Raises USD1.5 Million in Private Placement of Units 21
Citius Pharma Raises USD0.1 Million in Private Placement of Units 22
Citius Pharma Raises USD2.04 Million in Private Placement of Shares 23
Acquisition 24
Citius Pharma Acquires Leonard Meron Biosciences 24
Trail One Acquires Citius Pharma in Reverse Takeover Transaction 25
Citius Pharmaceuticals Inc – Key Competitors 26
Citius Pharmaceuticals Inc – Key Employees 27
Citius Pharmaceuticals Inc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Corporate Communications 29
Jun 28, 2016: Citius Pharmaceuticals Announces Appointment of Dr. Eugene Holuka to Its Board of Directors 29
Clinical Trials 30
Feb 01, 2016: Citius Pharmaceuticals Announces Results from Phase 2a Trial of Hydrocortisone and Lidocaine Combination Cream in Patients with Grade I and II Hemorrhoids 30
Other Significant Developments 31
Oct 11, 2017: Citius Pharmaceuticals Issues Shareholder Letter 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Citius Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Leonard-Meron Biosciences Raises USD0.6 Million in Venture Financing 10
Leonard Meron Biosciences Expands Licensing Agreement with Novel Anti-Infective Therapeutics 11
Citius Pharma Plans to Raise up to USD50 Million in Public Offering of Shares and Warrants 12
Citius Pharma Raises USD6.8 Million in Public Offering of Shares and Warrants 13
Citius Pharma Raises USD0.8 Million in Third Tranche of Private Placement of Units 15
Citius Pharma Raises USD0.2 Million in Seconds Tranche of Private Placement of Units 16
Citius Pharma Plans to Raise Funds in Public Offering of Shares 17
Citius Pharma Raises USD0.4 Million in Private Placement of Units 18
Citius Pharma Raises USD4.6 Million in Private Placement of Units 19
Citius Pharma Raises USD3 Million in Private Placement of Shares 20
Citius Pharma Raises USD1.5 Million in Private Placement of Units 21
Citius Pharma Raises USD0.1 Million in Private Placement of Units 22
Citius Pharma Raises USD2.04 Million in Private Placement of Shares 23
Citius Pharma Acquires Leonard Meron Biosciences 24
Trail One Acquires Citius Pharma in Reverse Takeover Transaction 25
Citius Pharmaceuticals Inc, Key Competitors 26
Citius Pharmaceuticals Inc, Key Employees 27
Citius Pharmaceuticals Inc, Subsidiaries 28

★海外企業調査レポート[Citius Pharmaceuticals Inc (CTXR)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pyng Medical Corp:医療機器:M&Aディール及び事業提携情報
    Summary Pyng Medical Corp (Pyng Medical), a subsidiary of Teleflex Medical Canada Inc, is a medical device company that manufactures and markets trauma and resuscitation products. The company offers products such as fast1 intraosseous infusion system, fastresponder sternal intraosseous device, mat t …
  • Petroleo Brasileiro S.A. (Petrobras):企業のM&A・事業提携・投資動向
    Petroleo Brasileiro S.A. (Petrobras) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Petroleo Brasileiro S.A. (Petrobras) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • University of Alberta-製薬・医療分野:企業M&A・提携分析
    Summary University of Alberta (UALBERTA) is an educational university that provides undergraduate, international, graduate, continuing studies and open studies programs. The university offers educational programs in agricultural food and nutritional science, English and film studies, history and cla …
  • Avanti Feeds Ltd (AVANTIFEED):企業の財務・戦略的SWOT分析
    Avanti Feeds Ltd (AVANTIFEED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Singulus Technologies AG (SNG):電力:M&Aディール及び事業提携情報
    Summary Singulus Technologies AG (Singulus Technologies) is an optical disc production line manufacturer that develops technologies for efficient and resource-conserving production processes. The company offers optical disc solutions such as blu-ray disc, CD, and DVD production equipment. Its solar …
  • SunTrust Wealth Management:企業の戦略・SWOT・財務情報
    SunTrust Wealth Management - Strategy, SWOT and Corporate Finance Report Summary SunTrust Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Oryzon Genomics SA (ORY):企業の財務・戦略的SWOT分析
    Summary Oryzon Genomics SA (Oryzon) is a clinical-stage biopharmaceutical company that offers discovers and develops epigenetic therapies to treat oncology and neurodegenerative diseases. The company offers epigenetics, a regulatory system that controls gene expression without affecting the makeup o …
  • Orkuveita Reykjavikur-エネルギー分野:企業M&A・提携分析
    Summary Orkuveita Reykjavikur (Orkuveita) is a public utility company that provides electricity and water. The company generates and supplies electricity. It harnesses hot water from geothermal fields and supplies it for heating applications. The company also supplies cold water from its groundwater …
  • Quadra – Power Generation:企業の発電所・SWOT分析2018
    Quadra - Power Generation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Sonangol EP:企業のM&A・事業提携・投資動向
    Sonangol EP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sonangol EP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Cardinal Health, Inc.:企業の戦略・SWOT・財務情報
    Cardinal Health, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cardinal Health, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Applied Maths NV:医療機器:M&Aディール及び事業提携情報
    Summary Applied Maths NV (Applied Maths), a subsidiary of bioMerieux SA, is a bioinformatics company that designs, develops and markets bioscience software products. The company offers software products such as bionumerics, gelcompar II, bionumerics server and bionumerics calculation engine. Its bio …
  • Ortho-Clinical Diagnostics Inc:企業のM&A・事業提携・投資動向
    Ortho-Clinical Diagnostics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ortho-Clinical Diagnostics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Saudi Arabian Mining Co:企業の戦略・SWOT・財務情報
    Saudi Arabian Mining Co - Strategy, SWOT and Corporate Finance Report Summary Saudi Arabian Mining Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PAREXEL International Corporation:企業の戦略・SWOT・財務情報
    PAREXEL International Corporation - Strategy, SWOT and Corporate Finance Report Summary PAREXEL International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Northern Ireland Electricity Networks Ltd:企業の戦略的SWOT分析
    Northern Ireland Electricity Networks Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Dragon Oil Plc:企業の戦略的SWOT分析
    Dragon Oil Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • NuScale Power LLC-エネルギー分野:企業M&A・提携分析
    Summary NuScale Power, LLC (NuScale), a subsidiary of Fluor Enterprises, Inc., is an energy equipment provider that designs and develops small, light water, and modular nuclear reactors based on light water reactor technology. It offers carbon-free nuclear power through its NuScale Power Module (NPM …
  • Origin Energy Ltd (ORG):電力:M&Aディール及び事業提携情報
    Summary Origin Energy Ltd (Origin Energy) is an integrated energy company. It generates, supplies and distributes electricity; explores and develops natural gas reserves; and produces and sells gas. The company generates electricity from natural-gas fired, coal-fired, wind, solar, pumped water stora …
  • EQT Corp (EQT):石油・ガス:M&Aディール及び事業提携情報
    Summary EQT Corp (EQT) is an integrated oil and gas company. It operates production fields in Marcellus, Upper Devonian, Ohio Utica and other plays in Appalachian Basin. The company produces and markets natural gas, natural gas liquids (NGL), ethane and crude oil. EQT provides gathering, transmissio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆